Linglu Dun
Liuzhou, 545001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
FABP4 as a Key Target of Hederagenin in Ischemic Stroke: A Study Based on Network Pharmacology and Experimental Validation.
Journal: Current neurovascular research
Published: January 30, 2026
Multiple sclerosis burden and quality of care index in China and the G20 (1990-2021): A cross-regional analysis using global burden of disease database 2021.
Journal: Medicine
Published: September 23, 2025
Neuroprotective effects of exosomes derived from bone marrow mesenchymal stem cells treated by Musk Ketone on ischemic stroke.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: May 04, 2023
The neuroprotective effect of YaoYi-moxibustion on ischemic stroke by attenuating NK-κB expression in rats.
Journal: Annals of translational medicine
Published: May 30, 2022
ANTXR1 as a potential prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma identified by a weighted gene correlation network analysis.
Journal: Journal of gastrointestinal oncology
Published: October 21, 2021
Musk Ketone Induces Neural Stem Cell Proliferation and Differentiation in Cerebral Ischemia via Activation of the PI3K/Akt Signaling Pathway.
Journal: Neuroscience
Published: August 20, 2019
Silencing of PTGS2 exerts promoting effects on angiogenesis endothelial progenitor cells in mice with ischemic stroke via repression of the NF-κB signaling pathway.
Journal: Journal of cellular physiology
Published: December 03, 2018
Suppression of lncRNA RMRP ameliorates oxygen-glucose deprivation/re-oxygenation-induced neural cells injury by inhibiting autophagy and PI3K/Akt/mTOR-mediated apoptosis.
Journal: Bioscience reports
Published: August 16, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026